AUPH Aurinia Pharmaceuticals Inc PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Aurinia Pharmaceuticals (AUPH) Stock: Buy, Sell, or Hold?

$16.32
+0.11 (+0.68%) ▲
5d: +0.68% 30d: -1.75% 90d: +5.49%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (55%)
Quality Score
54/100
Position
SLIGHTLY LOW
30-Day Fair Range
$16.15 – $17.03
Position: SLIGHTLY LOW
Forward P/E & Valuation
14.0x CHEAP
vs 15.8x historical avg
Wall Street Target
$18.29
+12.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$15.75 / $17.40
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: AUPH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Nov 3, 2026 at $16.59 · last confirmed Nov 11, 2026

Strength: 6.9/10

Get Alerted When AUPH Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$31.82
Based on 11.8% avg growth
INTRINSIC VALUE TODAY
$19.76
17.4% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.8x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: AUPH is currently trading at $16.32, which is considered slightly low relative to its 30-day fair value range of $16.15 to $17.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.0) compared to its historical average (15.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.0% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, AUPH is in a strong uptrend. Immediate support is located at $15.75, while resistance sits at $17.40.

Market Sentiment: AUPH scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.29 (+12.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $16.15 - $17.03
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 54.8%

Trading Range & Key Levels

30-Day Trading Range $16.15 - $17.03
Current vs Trading Range SLIGHTLY LOW
Support Level $15.75
Resistance Level $17.40
Current Trend Strong Uptrend
Technical data as of Nov 12, 2026

Protect Your Profits

Holding AUPH? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (36/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($18.29)

Fundamental Context

Forward P/E (Next Year Est.) 13.97
Wall Street Target $18.29 (+12.8%)
Revenue Growth (YoY) 13.9%
Profit Margin 97.7%
Valuation Discount vs History -4.0% cheaper
PE vs Historical 14.0 vs 15.8 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -4.0% (market-implied from PE analysis)
1-Year Target $15.56 (-4%)
2-Year Target $14.94 (-8%)
3-Year Target $14.34 (-12%)
3-Yr Target (if PE normalizes) (PE: 14→16) $16.22 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 19.6%) $39.40 (+143%)
Base: (SPY PE: 14.0, Growth: 19.6%) $27.72 (+71%)
Bear: (PE: 11.9, Growth: 19.6%) $23.56 (+45%)
📈 Valuation based on Current Earnings
Trailing PE: 7.15 | Current EPS (TTM): $2.28
Bull Case $9.12 (-44%)
Analyst growth -49.1%, PE expands to 7.9
Base Case $8.29 (-49%)
Market implied -49.1%, PE stable at 7.2
Bear Case $11.08 (-32%)
Severe decline -20.0%, PE contracts to 6.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.0 to 15.8
Stabilization Target: $18.33 (+13.1%)
PE Expansion Potential: +13.1%
Share AUPH Analysis

Share this live AUPH analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (AUPH)

Bullish 9 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
8 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits is filled with bullish sentiment towards $AUPH, with traders expressing optimism and excitement about potential price movements.
Key Retail Themes: Price optimism Anticipation of catalysts
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:00 PM ET
Data refreshes hourly during market hours. Next update: 3:00 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for AUPH.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$302 51 HOLD
VRTX
Vertex Pharmaceuticals I…
STRONG BUY
32 analysts
$592 39 SELL
ONC
BeOne Medicines AG
STRONG BUY
27 analysts
$438 30 SELL
ASND
Ascendis Pharma AS
STRONG BUY
21 analysts
$304 36 SELL
ORIC
Oric Pharmaceuticals Inc
STRONG BUY
15 analysts
$22 67 BUY

Advanced AUPH Option Strategies

Professional options setups generated by AI based on today's AUPH price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive AUPH Research Pages
AUPH Technical Chart AUPH Price Prediction AUPH Intrinsic Value DCF AUPH Earnings Date AUPH Investment Advisor AUPH Fair Price Analyzer AUPH Options Chain AUPH Options Advisor AUPH Options Analysis AUPH Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals